R. Danielsson et al., The role of scintimammography with Tc-99m-sestamibi as a complementary diagnostic technique in the detection of breast cancer, ACT RADIOL, 41(5), 2000, pp. 441-445
Purpose: To prospectively determine the clinical Value of scintimammography
(Sc) with Tc-99m-sestamibi as a complementary method to triple diagnosis (
TD) in detecting malignant disease of the breast.
Material and Methods. Ninety-six patients with 119 clinically or mammograph
ically detected breast lesions underwent TD procedures, including clinical
examination, mammography and fine-needle aspiration cytology. Prone planar
Sc with Tc-99m-sestamibi was performed in all 96 patients. Five groups were
defined for diagnosis: 1=normal; 2=benign; 3=probably benign; 4=highly sus
pect of malignancy; and 5=malignant. All lesions were histopathologically e
xamined. The results of each method pet se and the combination of TD with S
c (TD+Sc) were analyzed.
Results: Histopathology of the 119 surgically excised breast lesions found
83 malignant and 36 benign lesions. TD missed 6 of 83 carcinomas, resulting
in a sensitivity of 92.7%. Sc alone showed sensitivity of 85.5%. The combi
nation TD+Sc missed 1 of 83 carcinomas, and thus had a sensitivity of 98.7%
. In mammographically dense breasts both TD and Sc detected 16 of 18 carcin
omas, while the combination TD+Sc led to detection of all 18 carcinomas.
Conclusion. Adding Sc to TD increases the sensitivity for detection of brea
st carcinomas. Sc with Tc-99m-sestamibi is recommended as a complimentary m
ethod to TD in selected cases such as mammographically dense breasts.